Option Care HealthOPCH
OPCH
About: Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Employees: 7,802
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
250% more call options, than puts
Call options by funds: $9.73M | Put options by funds: $2.78M
10% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 107
5% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 74
1% less funds holding
Funds holding: 335 [Q3] → 332 (-3) [Q4]
4.04% less ownership
Funds ownership: 100.18% [Q3] → 96.13% (-4.04%) [Q4]
29% less capital invested
Capital invested by funds: $5.36B [Q3] → $3.79B (-$1.56B) [Q4]
100% less funds holding in top 10
Funds holding in top 10: 3 [Q3] → 0 (-3) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$26
19%
downside
Avg. target
$33
2%
upside
High target
$40
25%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
JP Morgan Lisa Gill 57% 1-year accuracy 13 / 23 met price target | 25%upside $40 | Overweight Maintained | 24 Jan 2025 |
Jefferies Brian Tanquilut 54% 1-year accuracy 7 / 13 met price target | 9%upside $35 | Buy Upgraded | 23 Jan 2025 |
Barrington Research Michael Petusky 55% 1-year accuracy 39 / 71 met price target | 3%upside $33 | Outperform Maintained | 14 Jan 2025 |
JMP Securities Constantine Davides 40% 1-year accuracy 12 / 30 met price target | 6%downside $30 | Market Outperform Reiterated | 10 Jan 2025 |
UBS A.J. Rice 31% 1-year accuracy 5 / 16 met price target | 19%downside $26 | Neutral Initiated | 5 Dec 2024 |
Financial journalist opinion
Positive
Zacks Investment Research
3 weeks ago
Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?
Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Neutral
Zacks Investment Research
1 month ago
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.
Positive
Zacks Investment Research
1 month ago
4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poised to gain.
Neutral
GlobeNewsWire
1 month ago
Option Care Health Announces Preliminary Financial Results for Fourth Quarter and Full Year 2024 and Preliminary Financial Expectations for Full Year 2025
BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024.
Neutral
GlobeNewsWire
2 months ago
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
BANNOCKBURN, Ill., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the 43rd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Monday, January 13, 2025, including a presentation at 1:30pm PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com.
Neutral
Seeking Alpha
3 months ago
Option Care Health, Inc. (OPCH) Q3 2024 Earnings Call Transcript
Option Care Health, Inc. (NASDAQ:OPCH ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Nicole Maggio – Senior Vice President-Finance John Rademacher – President and Chief Executive Officer Mike Shapiro – Chief Financial Officer Conference Call Participants David MacDonald – Truist Constantine Davides – Citizens JMP Securities Lisa Gill – JPMorgan Matt Larew – William Blair Brian Tanquilut – Jefferies Jamie Perse – Goldman Sachs Pito Chickering – Deutsche Bank Joanna Gajuk – Bank of America Operator Good day and thank you for standing by. Welcome to the Option Care Health Third Quarter 2024 Earnings Conference Call.
Positive
Zacks Investment Research
3 months ago
Option Care (OPCH) Surpasses Q3 Earnings and Revenue Estimates
Option Care (OPCH) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.31 per share a year ago.
Neutral
GlobeNewsWire
3 months ago
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2024
BANNOCKBURN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024.
Positive
Kiplinger
4 months ago
The Best Growth Stocks to Buy
Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.
Neutral
GlobeNewsWire
4 months ago
Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference Call
BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
Charts implemented using Lightweight Charts™